Masao Matsuoka

Q: What Schools Are Affiliated With Masao Matsuoka

Masao Matsuoka is affiliated with the following schools: Kyoto University, University of Nebraska Medical Center, Kanazawa Medical University, University of California, Berkeley, University of Tokyo, Institute of Science Tokyo, Kumamoto University

Masao Matsuoka's AcademicInfluence.com Rankings

Masao Matsuoka

Computer Science

#6863

World Rank

#7229

Historical Rank

Machine Learning

#2362

World Rank

#2391

Historical Rank

Artificial Intelligence

#2644

World Rank

#2685

Historical Rank

Database

#3941

World Rank

#4099

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Masao Matsuoka's Degrees

PhD Computer Science University of Tokyo
Masters Computer Science University of Tokyo
Bachelors Computer Science University of Tokyo

Similar Degrees You Can Earn

Why Is Masao Matsuoka Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Masao Matsuoka's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation (2007) (795)
Integrated molecular analysis of adult T cell leukemia/lymphoma (2015) (600)
HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. (2006) (554)
Revisiting Human IL-12R&bgr;1 Deficiency: A Survey of 141 Patients From 30 Countries (2010) (339)
Genetic and epigenetic inactivation of tax gene in adult T‐cell leukemia cells (2004) (321)
Novel HIV-1 integrase inhibitors derived from quinolone antibiotics. (2006) (309)
Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. (1997) (296)
HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo (2011) (275)
Broad Antiretroviral Activity and Resistance Profile of the Novel Human Immunodeficiency Virus Integrase Inhibitor Elvitegravir (JTK-303/GS-9137) (2007) (274)
Adult T-cell leukemia in Japan. (1996) (270)
Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. (1996) (249)
Switch circular DNA formed in cytokine-treated mouse splenocytes: Evidence for intramolecular DNA deletion in immunoglobulin class switching (1990) (235)
Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy (2011) (232)
Natural history of adult T-cell leukemia/lymphoma and approaches to therapy (2005) (217)
Human T-cell leukemia virus type I and adult T-cell leukemia (2003) (191)
Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. (2008) (189)
Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms (2005) (187)
Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappaB ligand on adult T-cell leukemia cells. (2002) (168)
In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) (2009) (168)
Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. (1997) (168)
Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-kappaB. (2009) (167)
The HBZ gene, a key player in HTLV-1 pathogenesis (2009) (164)
Interleukin 1 gene expression in adult T cell leukemia. (1987) (161)
Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. (2001) (155)
Identification of Aberrantly Methylated Genes in Association with Adult T-Cell Leukemia (2004) (146)
Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL) (2005) (146)
Remodeling of gp41-C34 peptide leads to highly effective inhibitors of the fusion of HIV-1 with target cells. (2002) (146)
Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro (2004) (140)
4′-Ethynyl Nucleoside Analogs: Potent Inhibitors of Multidrug-Resistant Human Immunodeficiency Virus Variants In Vitro (2001) (138)
Transcriptional Control of Spliced and Unspliced Human T-Cell Leukemia Virus Type 1 bZIP Factor (HBZ) Gene (2008) (127)
Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report (2019) (127)
Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia. (2000) (126)
Essential residues in V(D)J recombination signals. (1994) (120)
Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140. (2001) (119)
HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator. (2011) (116)
Immunoglobulin switch circular DNA in the mouse infected with Nippostrongylus brasiliensis: evidence for successive class switching from mu to epsilon via gamma 1. (1990) (116)
Preferential Selection of Human T-Cell Leukemia Virus Type 1 Provirus Lacking the 5′ Long Terminal Repeat during Oncogenesis (2007) (114)
Detection of somatic DNA recombination in the transgenic mouse brain. (1991) (112)
APOBEC3G Generates Nonsense Mutations in Human T-Cell Leukemia Virus Type 1 Proviral Genomes In Vivo (2010) (111)
Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease. (1988) (110)
Sporadic on/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells (2018) (108)
Mechanism of Inhibition of HIV-1 Reverse Transcriptase by 4′-Ethynyl-2-fluoro-2′-deoxyadenosine Triphosphate, a Translocation-defective Reverse Transcriptase Inhibitor* (2009) (104)
Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma. (2015) (103)
Amino Acid Mutation N348I in the Connection Subdomain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confers Multiclass Resistance to Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors (2008) (103)
The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma. (2014) (102)
Reducing the global burden of HTLV‐1 infection: An agenda for research and action (2017) (102)
2'-deoxy-4'-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants. (2008) (101)
Role of HTLV‐1 proviral DNA load and clonality in the development of adult T‐cell leukemia/lymphoma in asymptomatic carriers (2004) (100)
Missense mutation of the interleukin-12 receptor beta1 chain-encoding gene is associated with impaired immunity against Mycobacterium avium complex infection. (2001) (100)
A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice. (2011) (99)
Activity against Human Immunodeficiency Virus Type 1, Intracellular Metabolism, and Effects on Human DNA Polymerases of 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine (2007) (98)
An IL‐27/Stat3 axis induces expression of programmed cell death 1 ligands (PD‐L1/2) on infiltrating macrophages in lymphoma (2016) (97)
Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis (2016) (92)
Human T-cell leukemia virus type I induces adult T-cell leukemia: from clinical aspects to molecular mechanisms. (2007) (91)
Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells. (2004) (91)
CXCR4 stimulates macropinocytosis: implications for cellular uptake of arginine-rich cell-penetrating peptides and HIV. (2012) (91)
Mutations Conferring Resistance to Human Immunodeficiency Virus Type 1 Fusion Inhibitors Are Restricted by gp41 and Rev-Responsive Element Functions (2005) (89)
HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals (2012) (87)
Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia. (1987) (85)
Cooperation of NF-κB2/p100 Activation and the PDZ Domain Binding Motif Signal in Human T-Cell Leukemia Virus Type 1 (HTLV-1) Tax1 but Not HTLV-2 Tax2 Is Crucial for Interleukin-2-Independent Growth Transformation of a T-Cell Line (2007) (84)
Human T-cell leukemia virus type 1: replication, proliferation and propagation by Tax and HTLV-1 bZIP factor. (2013) (84)
Molecular mechanisms of HTLV-1 infection and pathogenesis (2011) (83)
ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells (2011) (81)
Clinical outcomes of a novel therapeutic vaccine with Tax peptide‐pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study (2015) (80)
Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells. (1998) (78)
Maximizing Functional Photoreceptor Differentiation From Adult Human Retinal Stem Cells (2009) (77)
Peptide bond mimicry by (E)-alkene and (Z)-fluoroalkene peptide isosteres: synthesis and bioevaluation of alpha-helical anti-HIV peptide analogues. (2009) (77)
Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4+25+ HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis (2002) (77)
Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma. (2010) (74)
SC29EK, a Peptide Fusion Inhibitor with Enhanced α-Helicity, Inhibits Replication of Human Immunodeficiency Virus Type 1 Mutants Resistant to Enfuvirtide (2008) (74)
SKI and MEL1 Cooperate to Inhibit Transforming Growth Factor-β Signal in Gastric Cancer Cells* (2009) (74)
Preferential selection of human T-cell leukemia virus type I provirus integration sites in leukemic versus carrier states. (2005) (73)
Autocrine stimulation of interleukin 1 beta in acute myelogenous leukemia cells (1987) (72)
HTLV-1 bZIP factor dysregulates the Wnt pathways to support proliferation and migration of adult T-cell leukemia cells (2013) (69)
HBZ and its roles in HTLV-1 oncogenesis (2012) (68)
HTLV-1 bZIP factor enhances TGF-beta signaling through p300 coactivator (2011) (67)
HTLV-1 bZIP Factor RNA and Protein Impart Distinct Functions on T-cell Proliferation and Survival. (2015) (67)
HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes. (2009) (66)
Mutation of CD95 (Fas/Apo-1) Gene in Adult T-Cell Leukemia Cells (1998) (66)
Syntheses of 4‘-C-Ethynyl-β-d-arabino- and 4‘-C-Ethynyl-2‘-deoxy-β-d-ribo-pentofuranosylpyrimidines and -purines and Evaluation of Their Anti-HIV Activity (2000) (65)
HTLV-1 bZIP Factor Induces Inflammation through Labile Foxp3 Expression (2013) (64)
Loss of interleukin-2-dependency in HTLV-I-infected T cells on gene silencing of thioredoxin-binding protein-2 (2006) (63)
Mogamulizumab (Anti‐CCR4) in HTLV‐1–Associated Myelopathy (2018) (63)
HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT) (2016) (62)
A novel diagnostic method of adult T-cell leukemia: monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction. (1994) (60)
De Novo Human T-Cell Leukemia Virus Type 1 Infection of Human Lymphocytes in NOD-SCID, Common γ-Chain Knockout Mice (2006) (59)
Rapid quantification of HTLV‐I provirus load: Detection of monoclonal proliferation of HTLV‐I‐infected cells among blood donors (1999) (59)
Cooperation of NF-kappaB2/p100 activation and the PDZ domain binding motif signal in human T-cell leukemia virus type 1 (HTLV-1) Tax1 but not HTLV-2 Tax2 is crucial for interleukin-2-independent growth transformation of a T-cell line. (2007) (58)
The 3′ enhancer region determines the B/T specificity and pro-B/pre-B specificity of immunoglobulin Vκ-Jκ joining (1995) (58)
Donor-derived T-cell leukemia after bone marrow transplantation. (2006) (57)
Synthesis and biological evaluation of selective CXCR4 antagonists containing alkene dipeptide isosteres. (2010) (56)
Human T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivo (2017) (56)
40 years of the human T-cell leukemia virus: past, present, and future (2019) (55)
HIV-1 Vpr Accelerates Viral Replication during Acute Infection by Exploitation of Proliferating CD4+ T Cells In Vivo (2013) (55)
Human T-cell leukemia virus type I at age 25: a progress report. (2005) (55)
HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines. (2012) (55)
Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor. (2015) (55)
Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome. (2008) (54)
Electrostatically constrained alpha-helical peptide inhibits replication of HIV-1 resistant to enfuvirtide. (2009) (54)
Human T-cell leukaemia virus type 1: parasitism and pathogenesis (2017) (53)
Human T-Cell Leukemia Virus Type 1 (HTLV-1) bZIP Factor Requires Cellular Transcription Factor JunD To Upregulate HTLV-1 Antisense Transcription from the 3′ Long Terminal Repeat (2012) (53)
Provirus Load in Patients with Human T‐Cell Leukemia Virus Type 1 Uveitis Correlates with Precedent Graves' Disease and Disease Activities (1998) (52)
Sea urchin insulator protects lentiviral vector from silencing by maintaining active chromatin structure (2004) (52)
A novel diagnostic method of adult T-cell leukemia: monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction (1994) (51)
HTLV-1 Viral Factor HBZ Induces CCR4 to Promote T-cell Migration and Proliferation. (2016) (51)
Design of a novel HIV-1 fusion inhibitor that displays a minimal interface for binding affinity. (2008) (50)
Gpr176 is a Gz-linked orphan G-protein-coupled receptor that sets the pace of circadian behaviour (2016) (50)
Constitutive overexpression of the L-selectin gene in fresh leukemic cells of adult T-cell leukemia that can be transactivated by human T-cell lymphotropic virus type 1 Tax. (1995) (50)
HTLV-1 bZIP factor: the key viral gene for pathogenesis (2020) (49)
Expression of FAP-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T cell lines derived from human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients. (1998) (49)
HTLV-1 bZIP factor suppresses apoptosis by attenuating the function of FoxO3a and altering its localization. (2014) (49)
HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors (2017) (45)
Clinical relevance of substitutions in the connection subdomain and RNase H domain of HIV-1 reverse transcriptase from a cohort of antiretroviral treatment-naïve patients. (2009) (45)
DNA double strand break repair enzymes function at multiple steps in retroviral infection (2009) (44)
T3 surface molecules on adult T cell leukemia cells are modulated in vivo (1986) (43)
Heptad Repeat-Derived Peptides Block Protease-Mediated Direct Entry from the Cell Surface of Severe Acute Respiratory Syndrome Coronavirus but Not Entry via the Endosomal Pathway (2007) (43)
T cell gamma gene rearrangements in hematologic neoplasms. (1987) (42)
Genetic evidence of transmission of human T cell lymphotropic virus type 1 between spouses. (2002) (42)
Leukaemogenic mechanism of human T‐cell leukaemia virus type I (2007) (41)
Synthesis and Application of Fluorescein‐ and Biotin‐Labeled Molecular Probes for the Chemokine Receptor CXCR4 (2008) (40)
Design of Peptide-based Inhibitors for Human Immunodeficiency Virus Type 1 Strains Resistant to T-20* (2009) (40)
2′-Deoxy-4′-C-Ethynyl-2-Fluoroadenosine: A Nucleoside Reverse Transcriptase Inhibitor with Highly Potent Activity Against Wide Spectrum of HIV-1 Strains, Favorable Toxic Profiles, and Stability in Plasma (2007) (40)
Structural Basis for the Interaction of CCR5 with a Small Molecule, Functionally Selective CCR5 Agonist (2006) (38)
Borna disease virus and the consumption of raw horse meat (1996) (38)
Resistance Profiles of Novel Electrostatically Constrained HIV-1 Fusion Inhibitors* (2010) (38)
Immunoglobulin V gene replacement is caused by the intramolecular DNA deletion mechanism. (1992) (38)
Design, Efficient Synthesis, and Anti‐HIV Activity of 4′‐C‐Cyano‐ and 4′‐C‐Ethynyl‐2′‐deoxy Purine Nucleosides (2004) (36)
Adult T cell leukemia cell lines that originated from primary leukemic clones also had a defect of expression of CD3-T cell receptor complex. (1988) (36)
Polymorphism of the 5'-flanking region of the tumor necrosis factor (TNF)-alpha gene and susceptibility to human T-cell lymphotropic virus type I (HTLV-I) uveitis. (1999) (36)
Characterization of simian T-cell leukemia virus type 1 in naturally infected Japanese macaques as a model of HTLV-1 infection (2013) (36)
HTLV-1 and the host immune system: how the virus disrupts immune regulation, leading to HTLV-1 associated diseases. (2010) (35)
Phase II Study of Cladribine (2-Chlorodeoxyadenosine) in Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma (2003) (35)
Potent CXCR4 antagonists containing amidine type Peptide bond isosteres. (2011) (34)
Central nervous system lesions in adult T-cell leukaemia: MRI and pathology (2002) (34)
Rearrangements of T-cell antigen receptor delta chain gene in hematologic neoplasms. (1989) (33)
Erratum: HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells (Proceedings of the National Academy of Sciences of the United States of America (January 17, 2006) 3, 103 (720-725) DOI: 10.1073/pnas.0507631103) (2006) (33)
Adult T cell leukemia following HTLV-I-associated myelopathy/tropical spastic paraparesis: case reports and implication to the natural course of ATL. (1995) (32)
HTLV-1 bZIP factor protein targets the Rb/E2F-1 pathway to promote proliferation and apoptosis of primary CD4+ T cells (2016) (31)
Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-alpha, and HLA-DRB1 gene polymorphisms in human T-cell lymphotropic virus type I associated myelopathy. (2000) (29)
HTLV-1 bZIP factor gene: Its roles in HTLV-1 pathogenesis. (2010) (29)
HTLV-2 APH-2 expression is correlated with proviral load but APH-2 does not promote lymphocytosis. (2012) (29)
Identification of novel non-peptide CXCR4 antagonists by ligand-based design approach. (2008) (29)
Random integration of HTLV-1 provirus: increasing chromosomal instability. (1998) (28)
Development of T cell lymphoma in HTLV-1 bZIP factor and Tax double transgenic mice (2014) (28)
An established CD4+ T lymphoma cell line derived from a patient with so-called Lennert's lymphoma: possible roles of cytokines in histopathogenesis. (1988) (28)
Induction of Tac antigen and proliferation of myeloid leukemic cells by ATL-derived factor: comparison with other agents that promote differentiation of human myeloid or monocytic leukemic cells. (1986) (28)
Oncogenic spiral by infectious pathogens: Cooperation of multiple factors in cancer development (2017) (27)
[Treatment of adult T-cell leukemia-lymphoma]. (1994) (27)
Interferon-γ Promotes Inflammation and Development of T-Cell Lymphoma in HTLV-1 bZIP Factor Transgenic Mice (2015) (26)
HTLV-1 induces T cell malignancy and inflammation by viral antisense factor-mediated modulation of the cytokine signaling (2020) (25)
HTLV-1 Alters T Cells for Viral Persistence and Transmission (2018) (25)
TCF1 and LEF1 act as T-cell intrinsic HTLV-1 antagonists by targeting Tax (2015) (25)
Whole-genome landscape of adult T-cell leukemia/lymphoma. (2021) (25)
Establishment of a Seronegative Human T-Cell Leukemia Virus Type 1 (HTLV-1) Carrier State in Rats Inoculated with a Syngeneic HTLV-1-Immortalized T-Cell Line Preferentially Expressing Tax (1999) (24)
Detection of inducible nitric oxide synthase (iNOS) mRNA by RT-PCR in ATL patients and HTLV-I infected cell lines: clinical features and apoptosis by NOS inhibitor (1999) (24)
Leukemogenesis of Adult T-Cell Leukemia (2003) (24)
Characterization of three monoclonal antibodies (VAK3-5) that identify p24, core protein of human immunodeficiency virus, and its precursors. (1987) (24)
CADM1 is a diagnostic marker in early‐stage mycosis fungoides: Multicenter study of 58 cases (2018) (23)
Identification of minimal sequence for HIV-1 fusion inhibitors. (2008) (23)
Structure-activity relationship study of pyrimido[1,2-c][1,3]benzothiazin-6-imine derivatives for potent anti-HIV agents. (2012) (23)
Association between interleukin-6 gene polymorphism and human T-cell leukemia virus type I associated myelopathy. (2002) (22)
Stat3 inhibitor abrogates the expression of PD-1 ligands on lymphoma cell lines. (2017) (22)
Synonymous mutations in stem-loop III of Rev responsive elements enhance HIV-1 replication impaired by primary mutations for resistance to enfuvirtide. (2009) (22)
HTLV-1 bZIP factor supports proliferation of adult T cell leukemia cells through suppression of C/EBPα signaling (2013) (21)
Circadian clock regulates hepatic polyploidy by modulating Mkp1-Erk1/2 signaling pathway (2017) (21)
AUTOCRINE STIMULATION OF INTERLEUKIN 10 IN ACUTE MYELOGENOUS LEUKEMIA CELLS (1987) (21)
Regulation of Latency in the Human T Cell Leukemia Virus, HTLV-1. (2019) (21)
Human T-cell leukemia virus type 1 and Foxp3 expression: viral strategy in vivo. (2014) (20)
GANP suppresses DNA recombination, measured by direct‐repeat β‐galactosidase gene construct, but does not suppress the type of recombination applying to immunoglobulin genes in mammalian cells (2007) (20)
Chapter 29 – Human T-Cell Leukemia Virus Type I (2006) (20)
Characterization of mRNA Expression of IκBα and NF‐κB Subfamilies in Primary Adult T‐cell Leukemia Cells (1998) (20)
Concise synthesis and anti-HIV activity of pyrimido[1,2-c][1,3]benzothiazin-6-imines and related tricyclic heterocycles. (2012) (20)
Sequential change of virus markers in seroconverters with community-acquired infection of human T lymphotropic virus type I. (2001) (20)
Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF- B (2009) (20)
PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4 (2017) (19)
Lack of the expression of EBNA-2 and LMP-1 in T-cell neoplasms possessing Epstein-Barr virus (1995) (19)
The noncanonical role of EZH2 in cancer (2021) (19)
Halogenated thymidine analogues restore the expression of silenced genes without demethylation. (2005) (19)
Long Noncoding RNA ANRIL Supports Proliferation of Adult T-Cell Leukemia Cells through Cooperation with EZH2 (2018) (19)
The possible involvement of CXCR4 in the inhibition of HIV‐1 infection mediated by DP178/gp41 (2000) (19)
Phenotypic and Genotypic Comparisons of Human T-Cell Leukemia Virus Type 1 Reverse Transcriptases from Infected T-Cell Lines and Patient Samples (2007) (19)
T3 surface molecules on adult T cell leukemia cells are modulated in vivo. (1986) (19)
A critical role for IL-17RB signaling in HTLV-1 tax-induced NF-κB activation and T-cell transformation (2015) (18)
Molecular and Cellular Mechanism of Leukemogenesis of ATL: Emergent Evidence of a Significant Role for HBZ in HTLV-1-Induced Pathogenesis (2011) (18)
Novel patterns of nevirapine resistance-associated mutations of human immunodeficiency virus type 1 in treatment-naïve patients. (2004) (18)
TIM-3 expression in lymphoma cells predicts chemoresistance in patients with adult T-cell leukemia/lymphoma. (2016) (18)
2'-Deoxy-4'-C-ethynyl-2-fluoroadenosine: a nucleoside reverse transcriptase inhibitor with highly potent activity against all HIV-1 strains, favorable toxic profiles and stability in plasma. (2006) (18)
Influence of cytokine and mannose binding protein gene polymorphisms on human T-cell leukemia virus type I (hTLV-I) provirus load in HTLV-I asymptomatic carriers. (2003) (17)
A Critical Role for IL-17RB Signaling in HTLV-1 Tax-Induced NF-κB Activation and T-Cell Transformation (2014) (17)
Studies of nonnucleoside HIV-1 reverse transcriptase inhibitors. Part 1: Design and synthesis of thiazolidenebenzenesulfonamides. (2004) (17)
Primary adult T cell leukemia of bone: two patients with primary bone lesion showing monoclonal integration of HTLV-I proviral DNA. (1996) (17)
Structure-activity relationship study of phenylpyrazole derivatives as a novel class of anti-HIV agents. (2013) (17)
Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib‐sensitive and ‐resistant multiple myeloma cells (2019) (17)
Implication of the HTLV- I bZIP Factor Gene in the Leukemogenesis of Adult T-Cell Leukemia (2007) (17)
Studies of non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: synthesis and structure-activity relationships of 2-cyano and 2-hydroxy thiazolidenebenzenesulfonamide derivatives. (2005) (17)
Design and synthesis of biotin- or alkyne-conjugated photoaffinity probes for studying the target molecules of PD 404182. (2013) (16)
Aberrant expression of the MEL 1 S gene identified in association with hypomethylation in adult T-cell leukemia cells (2004) (16)
X-ray crystallographic study of an HIV-1 fusion inhibitor with the gp41 S138A substitution. (2009) (16)
Virological and immunological mechanisms in the pathogenesis of human T‐cell leukemia virus type 1 (2013) (16)
Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence (2021) (16)
Gene rearrangements of T cell receptor beta and gamma chains in HTLV-I infected primary neoplastic T cells. (1988) (16)
Potential anti-lymphoma effect of M-CSFR inhibitor in adult T-cell leukemia/lymphoma (2018) (16)
Adult T‐cell leukemia‐lymphoma as a viral disease: Subtypes based on viral aspects (2021) (15)
Identification of anti-HIV agents with a novel benzo[4,5]isothiazolo[2,3-a]pyrimidine scaffold. (2015) (15)
Characterization of HIV-1 resistance to a fusion inhibitor, N36, derived from the gp41 amino-terminal heptad repeat. (2010) (15)
Enhancement of anti-STLV-1/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibody (2016) (15)
Mutation of CD 95 ( Fas / Apo-1 ) Gene in Adult T-Cell Leukemia Cells (1998) (15)
Lack of the expression of EBNA-2 and LMP-1 in T-cell neoplasms possessing Epstein-Barr virus. (1995) (15)
Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia. (2020) (15)
Paroxysmal nocturnal hemoglobinuria: termination in acute monocytic leukemia and reappearance after chemotherapy with N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PL-AC) and vincristine. (1987) (14)
HTLV-1 bZIP factor suppresses TDP1 expression through inhibition of NRF-1 in adult T-cell leukemia (2017) (14)
Detection of HTLV‐1 by means of HBZ gene in situ hybridization in formalin‐fixed and paraffin‐embedded tissues (2011) (14)
HTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors (2016) (13)
HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP (2014) (13)
Expression of Tac antigen on human immature B-cell lineage leukemic cells. (1986) (13)
Expression of IL‐34 correlates with macrophage infiltration and prognosis of diffuse large B‐cell lymphoma (2019) (13)
Ars insulator identified in sea urchin possesses an activity to ensure the transgene expression in mouse cells. (2006) (13)
Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP (2018) (13)
A Novel Colorimetric Assay for CXCR4 and CCR5 Tropic Human Immunodeficiency Viruses (2006) (12)
Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation (2018) (12)
2′‐Deoxy‐4′‐C‐ethynyl‐2‐fluoroadenosine: A Nucleoside Reverse Transcriptase Inhibitor with Highly Potent Activity Against Wide Spectrum of HIV‐1 Strains, Favorable Toxic Profiles, and Stability in Plasma (2008) (12)
TUBB1 dysfunction in inherited thrombocytopenia causes genome instability (2019) (12)
Development of adult T-cell leukemia in donor-derived human T-cell leukemia virus type I-infected T cells after allogeneic bone marrow transplantation (2007) (12)
Investigations of possible prodrug structures for 2-(2-mercaptophenyl)tetrahydropyrimidines: reductive conversion from anti-HIV agents with pyrimidobenzothiazine and isothiazolopyrimidine scaffolds. (2015) (11)
HTLV-I provirus in the clinical subtypes of ATL. (1997) (11)
Synthetic peptide-based electrochemiluminescence immunoassay for anti-Borna disease virus p40 and p24 antibodies in rat and horse serum (2001) (11)
FOXP3+ regulatory and TIA‐1+ cytotoxic T lymphocytes in HIV‐associated Hodgkin lymphoma (2012) (11)
Chromosomal abnormalities in non‐hodgkin lymphoma with peripheral t‐cell type: Effect of HTLV‐I infection (1987) (11)
Evaluating the origin and virulence of a Helicobacter pylori cagA-positive strain isolated from a non-human primate (2018) (11)
Impact of HIV-1 infection pathways on susceptibility to antiviral drugs and on virus spread. (2015) (10)
Enhanced antibody-mediated neutralization of HIV-1 variants that are resistant to fusion inhibitors (2016) (10)
A simple, rapid, and sensitive system for the evaluation of anti-viral drugs in rats. (2012) (10)
Anti-HTLV-III and anti-HTLV-I antibodies and T cell subsets in hemophiliacs living in HTLV-I endemic and nonendemic areas of Japan. (1987) (10)
The 3' enhancer region determines the B/T specificity and pro-B/pre-B specificity of immunoglobulin V kappa-J kappa joining. (1995) (10)
Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells (2015) (9)
Binding of multivalent anionic porphyrins to V3 loop fragments of an HIV-1 envelope and their antiviral activity. (2010) (9)
Syntheses of 4'-C-ethynyl-beta-D-arabino- and 4'-C-ethynyl-2'-deoxy-beta-D-ribo-pentofuranosylpyrimidines and -purines and evaluation of their anti-HIV activity. (2000) (9)
Comprehensive In Vitro Analysis of Simian Retrovirus Type 4 Susceptibility to Antiretroviral Agents (2013) (9)
Deregulated c-fos modulates B cell responses to switch mediators. (1993) (9)
Analysis of anti-HTLV-I antibody by strip radioimmunoassay--comparison with indirect immunofluorescence assay, enzyme-linked immunosorbent assay and membrane immunofluorescence assay. (1986) (8)
Reevaluation of confirmatory tests for human T‐cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors (2015) (8)
IL-2/IL-2 Receptor Pathway Plays a Crucial Role in the Growth and Malignant Transformation of HTLV-1-Infected T Cells to Develop Adult T-Cell Leukemia (2020) (8)
Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities In Vitro and In Vivo (2019) (8)
Lysine Demethylase 5A Is Required for MYC-Driven Transcription in Multiple Myeloma. (2021) (8)
Conference Highlights of the 16th International Conference on Human Retrovirology: HTLV and Related Retroviruses, 26–30 June 2013, Montreal, Canada (2014) (8)
Bioorganic synthesis of end-capped anti-HIV peptides by simultaneous cyanocysteine-mediated cleavages of recombinant proteins. (2009) (8)
The Roles of Coinhibitory Receptors in Pathogenesis of Human Retroviral Infections (2018) (8)
Isolated Pancreatic Myeloid Sarcoma Associated with t(8;21)/RUNX1-RUNX1T1 Rearrangement (2017) (8)
Bioorganic synthesis of a recombinant HIV-1 fusion inhibitor, SC35EK, with an N-terminal pyroglutamate capping group. (2009) (8)
A Potential Link between Alternative Splicing of the NBS1 Gene and DNA Damage/Environmental Stress (2008) (7)
Constitutive overexpression of the L-selectin gene in fresh leukemic cells of adult T-cell leukemia that can be transactivated by human T- cell lymphotropic virus type 1 Tax (1995) (7)
Controlling leucine-zipper partner recognition in cells through modification of a-g interactions. (2014) (7)
Design and synthesis of membrane fusion inhibitors against the feline immunodeficiency virus. (2009) (7)
Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4. (2010) (7)
RNase S complex bearing arginine‐rich peptide and anti‐HIV activity (2005) (7)
Involvement of double-stranded RNA-dependent protein kinase and antisense viral RNA in the constitutive NFκB activation in adult T-cell leukemia/lymphoma cells (2014) (7)
Increasing Methylation of the CDKN 2 A Gene Is Associated with the Progression of Adult T-Cell Leukemia 1 (2000) (6)
Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variants (2022) (6)
Creation of Low Toxic Reverse-Transcriptase Inhibitory Nucleosides that Prevent the Emergence of Drug-Resistant HIV Variants (2006) (6)
Natural antibodies in sera from Japanese individuals infected with HTLV- I do not recognize HTLV-III (1985) (6)
Novel screening systems for HIV-1 fusion mediated by two extra-virion heptad repeats of gp41 (2008) (6)
ATL cells recognize self class II HLA antigens: implication to leukemogenesis. (1995) (6)
[HTLV-1 bZIP Factor (HBZ) gene has a growth-promoting effect on adult T-cell leukemia cells]. (2008) (6)
HIV-1 Resistance Mechanism to an Electrostatically Constrained Peptide Fusion Inhibitor That Is Active against T-20-Resistant Strains (2013) (6)
RUNX1-ETO (RUNX1-RUNX1T1) induces myeloid leukemia in mice in an age-dependent manner (2021) (6)
DNA diagnosis of HTLV-I. (1996) (5)
Mechanism of resistance to S138A substituted enfuvirtide and its application to peptide design. (2013) (5)
Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases (2021) (5)
Cell adhesion molecule-1 (CADM1) expressed on adult T-cell leukemia/lymphoma cells is not involved in the interaction with macrophages. (2017) (5)
Pancytopenia and Myelodysplastic Changes in Aceruloplasminemia: A Case with a Novel Pathogenic Variant in the Ceruloplasmin Gene (2018) (5)
Hematopoietic Stem Cell Infected with HTLV-1 Functions As a Viral Reservoir In Vivo (2016) (5)
Correction: Interferon-γ Promotes Inflammation and Development of T-Cell Lymphoma in HTLV-1 bZIP Factor Transgenic Mice (2015) (5)
IL-7R–Dependent Phosphatidylinositol 3-Kinase Competes with the STAT5 Signal to Modulate T Cell Development and Homeostasis (2020) (5)
Sea urchin arylsulfatase insulator exerts its anti-silencing effect without interacting with the nuclear matrix. (2006) (5)
A Small Molecule, ACAi-028, with Anti-HIV-1 Activity Targets a Novel Hydrophobic Pocket on HIV-1 Capsid (2021) (5)
Potent Anti-HIV-1 Activity of N-HR-Derived Peptides Including a Deep Pocket-Forming Region without Antagonistic Effects on T-20 (2011) (5)
Attempt to Reduce Cytotoxicity by Synthesizing the L-Enantiomer of 4′-C-Ethynyl-2′-Deoxypurine Nucleosides as Antiviral Agents against HIV and HBV (2004) (5)
HTLV-1 activates YAP via NF-κB/p65 to promote oncogenesis (2022) (5)
Impact of the SCF signaling pathway on leukemia stem cell-mediated ATL initiation and progression in an HBZ transgenic mouse model (2016) (5)
[Adult T-cell leukemia/lymphoma]. (1998) (5)
Experimental evaluation of the zoonotic infection potency of simian retrovirus type 4 using humanized mouse model (2015) (5)
Meeting report on the 13th International Conference on Human Retrovirology: human T-cell leukemia virus research 30 years after adult T-cell leukemia. (2007) (5)
[Chronic adult T-cell leukemia with T4 and T8 positive leukemic cells associated with central diabetes insipidus]. (1987) (4)
Development and application of fluorescent SDF-1 derivatives. (2012) (4)
In vivo dynamics and adaptation of HTLV-1-infected clones under different clinical conditions. (2021) (4)
M-Sec induced by HTLV-1 mediates an efficient viral transmission (2021) (4)
SOMATIC ALTERATIONS IN ADULT T-CELL LEUKEMIA CELLS (2003) (4)
HTLV-1 bZIP factor: the key viral gene for pathogenesis (2020) (4)
A B‐CELL LINE HAVING CHROMOSOME 14 ABERRATION AT BREAK BAND qll DERIVED FROM AN ADULT T‐CELL LEUKEMIA PATIENT (1988) (4)
A Conformational Escape Reaction of HIV-1 against an Allosteric Integrase Inhibitor (2020) (4)
Frequent horizontal and mother-to-child transmission may contribute to high prevalence of STLV-1 infection in Japanese macaques (2020) (4)
T Cell γ Chain Gene Rearrangement without T Cell Receptor β Chain Gene Rearrangement in Two Cases of Non-Hodgkin’s Lymphoma (1987) (4)
HTLV-1-mediated dysregulation of the Wnt pathways: roles of Tax and HBZ (2014) (4)
Dual-Reporter Phenotypic Assay for Human Immunodeficiency Viruses (2007) (4)
Epstein–Barr Viral Load is Associated to Response in AIDS-Related Lymphomas (2014) (4)
Beneficial impact of first‐line mogamulizumab‐containing chemotherapy in adult T‐cell leukaemia‐lymphoma (2022) (4)
A novel PDK1 inhibitor, JX06, inhibits glycolysis and induces apoptosis in multiple myeloma cells (2021) (4)
A regulatory element in the 3′‐untranslated region of CEBPA is associated with myeloid/NK/T‐cell leukemia (2020) (4)
[Apoptosis of peripheral leukocytes in patients with myelodysplastic syndromes]. (1998) (4)
Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients (2021) (3)
Synergistic inhibition of cell-to-cell HIV-1 infection by combinations of single chain variable fragments and fusion inhibitors (2019) (3)
[Apoptosis in infectious mononucleosis]. (1997) (3)
STLV-1-infected Japanese macaque as a model of HTLV-1 infection (2014) (3)
Correction: HTLV-1 bZIP Factor Enhances T-cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors (2017) (3)
Synthesis of 4′-C-Ethynyl and 4′-C-Cyano Purine Nucleosides from Natural Nucleosides and Their Anti-HIV Activity (2003) (3)
[Mechanism of oncogenesis by human T-cell leukemia virus type 1]. (2010) (3)
Natural antibodies in sera from Japanese individuals infected with HTLV-I do not recognize HTLV-III. (1985) (3)
Functional and Pathogenic Roles of Retroviral Antisense Transcripts (2022) (3)
Affinity selection and sequence-activity relationships of HIV-1 membrane fusion inhibitors directed at the drug-resistant variants (2010) (3)
Clinicopathological Study of Methotrexate-Associated Lymphoproliferative Disorders in Rheumatoid Arthritis Patients: Histological Classification and Predictive Factors for Disease Progression (2017) (3)
[Adult T-cell leukemia/lymphoma (ATL)]. (2001) (3)
[HTLV-I and leukemogenesis]. (2006) (3)
HTLV-III infection and epitope recognition by OKT4 monoclonal antibody. (1985) (3)
The structure and genomic integration site of the HTLV-1 provirus determine selective clonal expansion and transformation to adult T cell leukaemia/lymphoma (2014) (2)
Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy (2022) (2)
The phase-I study of a therapeutic vaccine to ATL patients with autologous dendritic cells pulsed with peptides corresponding to Tax-specific CTL epitopes (2014) (2)
HTLV-1 bZIP factor-mediated dysfunction of regulatory T cells in vivo (2011) (2)
Synthesis of 4'-ethynyl-purine nucleosides possessing anti-HIV activity. (2000) (2)
Integration site analysis in Japanese HTLV-1 infected asymptomatic carriers and HAM/TSP patients (2014) (2)
Prevention of acute graft-versus-host disease in adult T-cell leukemia–lymphoma patients who received mogamulizumab before allogeneic hematopoietic cell transplantation (2021) (2)
Landscape of Genetic Alterations in Adult T-Cell Leukemia/Lymphoma (2014) (2)
Binding Modes of Two Novel Non-Nucleoside Reverse Transcriptase Inhibitors, YM-215389 and YM-228855, to HIV Type-1 Reverse Transcriptase (2008) (2)
Analysis of antibody to neutrophils associated with autoimmune neutropenia: possible recognition of Fc-receptor-related molecules. (1986) (2)
HTLV-1 bZIP factor supports proliferation of adult T cell leukemia cells through suppression of C/EBPα signaling (2013) (2)
The Purine Metabolic Enzyme AMPD1 Is a Novel Therapeutic Target for Multiple Myeloma (2018) (2)
Development of a novel fusion inhibitor against T-20-resistant HIV-1. (2009) (2)
Genome wide association study of HTLV-1–associated myelopathy/tropical spastic paraparesis in the Japanese population (2021) (2)
t6A and ms2t6A Modified Nucleosides in Serum and Urine as Strong Candidate Biomarkers of COVID-19 Infection and Severity (2022) (2)
[Proteasome inhibitor, bortezomib (Vercade), potently inhibits the growth of adult T-cell leukemia cells]. (2004) (2)
Genotypic analysis of lymph node cells from patients with phenotypically undetermined cell lymphoma. (1987) (2)
[Spontaneous remission of acquired factor XIII inhibitor concurrent to development of IgA-λ type multiple myeloma]. (2019) (1)
A unique conformational escape reaction of HIV-1 against an allosteric integrase inhibitor (2019) (1)
Molecular and clinical analyses of HTLV-1 subgroups associated with the risk of developing HAM/TSP. (2015) (1)
Design and Synthesis of Highly Active Anti-HIV Peptide Based on Gp41-C34 Peptide (2002) (1)
Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma. (2021) (1)
Functional Impairment of Co-Inhibitory Receptors Promotes T-Cell Proliferation in HTLV-1 Associated Adult T-Cell Leukemia Cells (2016) (1)
APH-2 and Tax expression are correlated with a HTLV-2 proviral load but not with lymphocytosis (2011) (1)
Frequent Activating Somatic Alterations in T-Cell Receptor / NF-κb Signaling in Adult T-Cell Leukemia/Lymphoma (2015) (1)
Noncanonical Wnt5a Is Induced by HTLV-1 bZIP Factor, and Supports Proliferation and Migration of Adult T-Cell Leukemia Cell. (2012) (1)
The 2011 Retrovirology Prize winner Masao Matsuoka: forward looking and antisense. Interview by Kuan-Teh Jeang. (2011) (1)
Conference Highlights of the 16th International Conference on Human Retrovirology: HTLV and Related Retroviruses, 26–30 June 2013, Montreal, Canada (2014) (1)
JX06, a Novel PDK1 Inhibitor, Induces Myeloma Cell Apoptosis By Metabolic Reprogramming and Works Synergistically with Bortezomib (2019) (1)
Clinical potential of dual-energy cardiac CT in cardiac amyloidosis (2019) (1)
HTLV-1 Dysregulates IL-6 and IL-10-JAK/STAT Signaling and Induces Leukemia/Lymphoma of Mature CD4+ T Cells with Regulatory T-Cell-like Signatures (2019) (1)
Efficient horizontal transmission without viral super-spreaders may cause the high prevalence of STLV-1 infection in Japanese macaques (2019) (1)
HTLV-1 Dysregulates IL-6 and IL-10-JAK/STAT Signaling and Induces Leukemia/Lymphoma of Mature CD4+ T Cells with Regulatory T-Cell-like Signatures (2019) (1)
[Alleviation of palmoplantar pustulosis associated with adult T cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation]. (2012) (1)
The phase-I study of a therapeutic vaccine to ATL patients with autologous dendritic cells pulsed with peptides corresponding to Tax-specific CTL epitopes (2014) (1)
Feasibility of an intensified myeloablative conditioning regimen consisting of busulfan, fludarabine, cytarabine, and total body irradiation before single cord blood transplantation in elderly patients (2021) (1)
HTLV-1 bZIP factor induces systemic inflammations in vivo (2011) (1)
Clinical aspects of HTLV-1-associated cancer. (2010) (1)
Highlights of the 16 th International Conference on Human Retrovirology : HTLV and Related Retroviruses , 26 – 30 June 2013 , Montreal , Canada (2015) (1)
Gene Rearrangements in Hematologic Neoplasms (2005) (1)
HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP (2014) (1)
Molecular mechanisms of apoptosis suppression by HTLV-1 bZIP factor in HTLV-1 infected cells (2014) (1)
the classical pathway of NF-{kappa}B Human T-cell leukemia virus type 1 bZIP factor selectively suppresses (2009) (1)
Human T-Cell Leukemia Virus Type 1: Pathogenesis and Host Immune Response (2014) (1)
Role of miRNAs (miR‐93 and miR‐130b) in Human T‐cell Leukemia Virus‐1 (HTLV‐1) Transformation of Cells through Tumor Suppressor TP53INP1 Downregulation (2007) (1)
Effect of lenalidomide on antileukemia activity in vitro against adult T-cell leukemia (ATL). (2011) (1)
Lack of the Expression of EBNA-2 and LMP1 in T-cell Neoplasms Possessing (2000) (1)
[Morphological studies on cells from adult T cell leukemia. II. Lobulated lymphocytes and HTLV-I infection]. (1987) (1)
HTLV-1 bZIP factor perturbs immune response to the pathogens in vivo by inhibiting IFN-gamma production (2011) (1)
[Adult T-cell leukemia]. (2001) (1)
detected by inverse polymerase chain reaction integration of human T-cell lymphotropic virus type I provirus DNA A novel diagnostic method of adult T-cell leukemia: monoclonal (2010) (1)
Whole-Genome Analysis of Adult T-Cell Leukemia/Lymphoma (2020) (1)
Identification of TIGIT as an HBZ-induced gene by genome-wide analyses: its association with evasion of host defense (2015) (1)
[Detection of anti-HTLV-III antibodies in hemophiliacs--prevalence rates in Japan and comparison of two assay systems]. (1986) (1)
HTLV-1 bZIP factor suppresses c-Fos transcription and impairs T cell activation (2014) (1)
Title HTLV-1 bZIP Factor Induces Inflammation through Labile (2016) (1)
Overlap syndrome involving anti-OJ antibody-positive polymyositis, systemic lupus erythematosus and Sjögren's syndrome: A case report and literature review. (2022) (1)
[Follicular T-cell lymphoma successfully treated with long-term corticosteroid]. (2022) (1)
Title Electrostatically constrained α-helical peptide inhibits replication of HIV-1 resistant to enfuvirtide (2016) (1)
Daratumumab, lenalidomide and dexamethasone in newly diagnosed systemic light chain amyloidosis patients associated with multiple myeloma (2022) (1)
HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+T cells in virus-infected individuals (2012) (1)
ASSESSMENT OF POOR MOBILIZATION USING PERIPHERAL BLOOD STEM CELLS BY AN AUTOMATED HEMATOLOGY ANALYZER (2018) (1)
Predictive impact of soluble interleukin‐2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B‐cell lymphoma (2022) (1)
[Sensation of an increased pressure in the thoracic cavity, pleural effusion, splenomegaly and lymphadenitis: malignant lymphoma]. (1975) (1)
Relationship between Serum Bortezomib Concentration and Emergence of Diarrhea in Patients with Multiple Myeloma and/or AL Amyloidosis (2021) (1)
Molecular and clinical analyses of HTLV-1 subgroups associated with the risk of developing HAM/TSP. (2015) (0)
Tokuda Akihiro Tomida Shinya Toyokuni Hitoshi Tsuda Shoichiro Tsugane Tatsuhiko Tsunoda Heiichiro Udono Koji Ueda Yoshimasa Uehara Hiroo Ueno Kazuo Umezawa Toshikazu Ushijima Toshihiko Wakabayashi Kenji Wakai Tetsuro Watabe (2016) (0)
Methylation Profile of B-Chronic Lymphocytic Leukemia Cells. (2005) (0)
How human T-cell leukemia virus type 1 induces diseases (2013) (0)
G106 Pathogenic roles of HTLV-1 bZIP factor gene (2013) (0)
Clinical Pathophysiology of adult T-cell leukemia (1999) (0)
PERSISTENT HTLV-I INFECTION WITHOUT ANTIBODY RESPONSES IN RATS INOCULATED WITH A SYNGENEIC HTLV-I-IMMORTALIZED T CELL LINE (1999) (0)
Activity against Human Immunodeﬁciency Virus Type 1, Intracellular Metabolism, and Effects on Human DNA Polymerases of 4 (cid:2) -Ethynyl-2-Fluoro-2 (cid:2) -Deoxyadenosine (cid:1) (2007) (0)
[Mechanism of leukemogenesis by human T-cell leukemia virus type I: from infection with HTLV-I to the onset of adult T-cell leukemia]. (2006) (0)
HIV pathogenesis and immunity (WS-074) Chairpersons: Yoshio Koyanagi, Guido Poli (2010) (0)
153 Molecular pathogenesis by HTLV-1 bZIP factor (2014) (0)
Integration site analysis in Japanese HTLV-1 infected asymptomatic carriers and HAM/TSP patients (2014) (0)
[Recent progress in ATL and HTLV-1 research]. (2008) (0)
Guest editorial: a new era of ATL and HTLV-1 research (2011) (0)
Systematic clustering algorithm for chromatin accessibility data and its application to hematopoietic cells (2020) (0)
Frequent horizontal and mother-to-child transmission may contribute to high prevalence of STLV-1 infection in Japanese macaques (2020) (0)
Anti-CCR4 antibody activates virus specific immune response in STLV-1 infected Japanese monkey (2015) (0)
[A case of T-cell chronic lymphocytic leukemia with both helper and suppressor phenotype, and helper function]. (1986) (0)
Oligoarginine-mediated Delivery of Bioactive Peptides into Living cells (2003) (0)
HTLV-1 bZIP factor impairs DNA mismatch repair system. (2023) (0)
Development of Fusion-inhibiting Anti-HIV-1 Peptides Based on the Structure of Molecular Complex Involved in HIV-1-cell Fusion (2003) (0)
Unraveling the Structure of IL-2 (2005) (0)
Human T-cell leukemia virus type 1 : replication , proliferation and propagation by Tax and HTLV-1 bZIP factor Short title : Replication of human T-cell leukemia virus type 1 (2017) (0)
Report on the 13 th International Conference on Human Retrovirology : Human T-Cell Leukemia Virus Research 30 Years after Adult T-Cell Leukemia (2007) (0)
The structure and genomic integration site of the HTLV-1 provirus determine selective clonal expansion and transformation to adult T cell leukaemia/lymphoma (2014) (0)
H-103 Clinical landscape of adult T-cell leukemia: Its impacts on hematology, virology, and immunology (2019) (0)
Pseudo-progression of adult T-cell leukemia-lymphoma after cord blood transplantation (2022) (0)
The HTLV-1 proviral status is a potential prognostic biomarker for adult T-cell leukemia-lymphoma treated with allogeneic stem cell transplantation (2021) (0)
[Contact factors (factor XII and XI)--how to read its figures]. (1971) (0)
LEUKEMOGENESIS AND PROGRESSION OF ADULT T-CELL LEUKEMIA (1999) (0)
Novel Inhibition Mechanism and Potent Activity of Translocation-deficient Reverse Transcriptase Inhibitors (2008) (0)
Dual-Reporter Phenotypic Assay for Human Immunodeﬁciency Viruses (cid:1) (2008) (0)
Anti-CCR4 antibody activates virus specific immune response in STLV-1 infected Japanese monkey (2015) (0)
HTLV-1-mediated dysregulation of the Wnt pathways: roles of Tax and HBZ (2014) (0)
Crystal structure of the complex between gp41 fragments N36 and C34 mutant N126K/E137Q (2010) (0)
Systematic clustering algorithm for epigenetic data from high-throughput sequencing and its application to hematopoietic and leukemic cells. (2019) (0)
Derivatives of 2-haloadenosina 4'-C-substituted. (2005) (0)
Next-Generation Sequencing Reveal Proviral Genome and Transcriptome in Adult T-Cell Leukemia/Lymphoma (2015) (0)
[Astute strategies of HTLV-1 with driven viral genes]. (2019) (0)
Crystal structure of potent anti-HIV peptide, N36 complexed with C34KQ derived from N36-resistant strain (2001) (0)
Title HTLV-1 bZIP factor protein targets the Rb/E2F-1 pathway to promote proliferation and apoptosis of primary CD4+ T cells (2021) (0)
Evaluating the origin and virulence of a Helicobacter pylori cagA-positive strain isolated from a non-human primate (2018) (0)
How does HTLV-1 induce ATL? (2016) (0)
Altered Expression of CCR10 Indicates Malignant Transformation of Bone Marrow Plasma Cells (2017) (0)
My Views and Thoughts on Translational Medicine (2015) (0)
T cell gamma chain gene rearrangement without T cell receptor beta chain gene rearrangement in two cases of non-Hodgkin's lymphoma. (1987) (0)
Synthesis of Novel Anti-HIV Peptides Based on a CXCR4 Antagonist, T140, and Their SAR Study (2002) (0)
Reprogramming of lactate metabolism is linked to the oncogenesis of the virus-induced leukemia (2022) (0)
HTLV-1 bZIP factor suppresses TDP1 expression through inhibition of NRF-1 in adult T-cell leukemia (2017) (0)
PTCL: Lessons from adult T-cell leukemia (2002) (0)
Nucleosides 4'-ethynyl-c. (2000) (0)
[Molecular-targeted therapies against adult T-cell leukemia]. (2014) (0)
HIV-1 and HTLV-1:From Bench to Bedside (2006) (0)
Contents, Vol. 75, 1986 (1986) (0)
Aberrantly Hypermethylated Genes in Adult T-Cell Leukemia Cells: The Implications in the Leukemogenesis. (2004) (0)
HTLV-1 bZIP factor suppresses c-Fos transcription and impairs T cell activation (2014) (0)
X-ray Crystallographic Study of the HIV-1 Fusion Inhibitor against the Drug-Resistant N43D Variant (2009) (0)
Targeting Nicotinamide Adenine Dinucleotide (NAD) Glycohydrase Activity of CD38 Exerts Anti-Myeloma Effect Accompanying Intracellular NAD Elevation (2019) (0)
Development of T cell lymphoma in HTLV-1 bZIP factor and Tax double transgenic mice (2014) (0)
[Cytokine-induced class switch recombination]. (1991) (0)
Rapid Publication Interleukin 1 Gene Expression in Adult T Cell Leukemia (0)
Possible Association of Mutations in the MEFV Gene with the Intestinal Phenotype of Behçet’s Disease and Refractoriness to Treatment (2023) (0)
[Purpura and internal diseases]. (1966) (0)
Mutagenicity of wood smoke condensates in the Ames test (1991) (0)
Helix Inducible Motifs Affect Helicity and Bioactivity of Anti-HIV Peptides (2008) (0)
Title ATF 3 , an HTLV-1 bZip factor binding protein , promotesproliferation of adult T-cell leukemia cells (2019) (0)
Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP (2018) (0)
250 CADM1 is a diagnostic marker in early-stage mycosis fungoides (2017) (0)
Bioorganic Synthesis of End-capped HIV-1 Fusion Inhibitor SC35EK (2009) (0)
Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis (2016) (0)
Heptad repeat-derived peptides block the protease-mediated direct entry from cell surface of SARS coronavirus but not entry via endosomal pathway (2017) (0)
P-39 2'-DEXY-4'-C-ETHYNYL-2-FLUOROADENOSINE, A NRTI THAT COULD BE AN IDEAL DRUG FOR BOTH HIV-AND HBV-INFECTIONS (2006) (0)
[HTLV-I and genetic polymorphisms other than HLA]. (2000) (0)
Title Gpr 176 is a Gz-linked orphan G-protein-coupled receptor thatsets the pace of circadian behaviour (2016) (0)
Associations of cardiovascular risk factors with survival outcomes in a cancer registration (2021) (0)
Short Communication HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes (2009) (0)
HTLV-I bZIP Factor Gene, Encoded by the Minus Strand of HTLV-I Provirus, Is Critical for Pathogenesis of HTLV-I Associated Diseases. (2006) (0)
[Adult T-cell leukemia/lymphoma diagnosed by RNA in situ hybridization for HTLV-1 bZIP factor]. (2022) (0)
My Hope for the Surface Finishing Society of Japan (1990) (0)
HTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors (2015) (0)
[Molecular mechanism of leukemogenesis]. (2007) (0)
180 Adult T-Cell Leukemia/Lymphoma in Japan: Reminiscences and Perspectives (2011) (0)
HTLV-1 markers in three carriers who eventually developed adult T-cell leukemia in the Miyazaki Cohort Study (1999) (0)
The increased provirus load results from polyclonal expansion of CD4+25+ HTLV-1-infected T-cells in HTLV-1 carriers with S. Stercoralis infection (1999) (0)
Cardiac MRI-derived Extracellular Volume Fraction versus Myocardium-to-Lumen R1 Ratio at Postcontrast T1 Mapping for Detecting Cardiac Amyloidosis. (2023) (0)
[Evidence-based therapy for adult T-cell leukemia and the related leukemias]. (2003) (0)
4′-Ethynyl nucleoside analogues: Potent inhibitors active against multi-drug-resistant HIV variants (2001) (0)
Subject Index, Vol. 75, 1986 (1986) (0)
STLV-1-infected Japanese macaque as a model of HTLV-1 infection (2014) (0)
T-20-Resistant Strains Fusion Inhibitor That Is Active against Electrostatically Constrained Peptide HIV-1 Resistance Mechanism to an (2014) (0)
HTLV-1's Foxy Strategy for Survival and Transmission (2022) (0)
SUCCESSFUL ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN A PATIENT WITH ADULT T-CELL LEUKEMIA (1999) (0)
[Inhibitory effects of menogaril to the proliferation of HTLV-I infected T-cell lines and fresh tumor cells from adult T-cell leukemia patients]. (1995) (0)
Possible involvement of PKCβII activation in the progression of HTLV-1 Tax-immortalized T-cells (1999) (0)
Identification of Novel HIV-1 Fusion Inhibitors by Template-Assisted Peptide Aldehyde Ligation (2009) (0)
983PEXCELLENT QUALITY OF LIVES FOR PREVIOUSLY TREATED ADULT T-CELL LEUKEMIA/LYMPHOMA PATIENTS AFTER AUTOLOGOUS DENDRITIC CELL VACCINE THERAPY TARGETING HTLV-1 TAX ANTIGENS. (2014) (0)
Targeting the Plasma Cell Specific Purine Metabolic Enzyme, AMPD1, Induces Multiple Myeloma Cell Death Accompanying NAD Depletion (2019) (0)
How human T-cell leukemia virus type 1 induces diseases (2013) (0)
EGFR Mutations in Small-Cell Lung Cancers in Patients Who Have Never Smoked (2006) (0)
[Relation between characteristics and physiopathology of adult T-cell leukemia cells]. (1986) (0)
Nonsecretory myeloma: analysis of two patients by immunoperoxidase studies and plaque-forming cell assay. (1985) (0)
Phenotypic and Genotypic Comparisons of Human T-Cell Leukemia Virus Type 1 Reverse Transcriptases from Infected T-Cell Lines and Patient Samples (cid:1) (2007) (0)
Molecular mechanisms of apoptosis suppression by HTLV-1 bZIP factor in HTLV-1 infected cells (2014) (0)
Characterization of simian T-cell leukemia virus type 1 in naturally infected Japanese macaques as a model of HTLV-1 infection (2013) (0)
[Molecular pathogenesis by human T-cell leukemia virus type 1]. (2011) (0)
HUMAN LEUKOCYTE ANTIGENS ASSOCIATED WITH ANTIBODY RESPONSE AND PROVIRAL LOAD OF HTLV-I. (1999) (0)
Title HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM (2019) (0)
lymphohistiocytosis in humanized mice associated hemophagocytic - A novel animal model of Epstein-Barr virus (2011) (0)
Establishment of Novel Disease Models for Human Acute Type ATL and HTLV-I Carrier Using NOD-scid/IL2rg null Mouse. (2007) (0)
A Therapeutic Vaccine In Adult T-Cell Leukemia Patients With Autologous Dendritic Cells Pulsed With Peptides Corresponding To Tax-Specific Cytotoxic T Lymphocyte Epitopes (2013) (0)
Title Human T-cell leukemia virus type 1 Tax oncoprotein repressesthe expression of the BCL 11 B tumor suppressor in T-cells (2018) (0)
The Role of CD38 in Multiple Myeloma Cell Biology (2021) (0)
Dynamic Changes of Chromatin Structure and Transcriptome By Transient Expression of HTLV-1 Tax in ATL Cells (2018) (0)
[An autopsy case of atypical adult T-cell leukemia (ATL) with skin lesions of 15-years' duration and renal failure]. (1983) (0)
Structure Activity Relationship Study of the Helix-inducible Motifs in HIV Fusion Inhibitors (2009) (0)
[HTLV-1: Recent topics in epidemiologic, basic and clinical research]. (2013) (0)
Oncofetal Protein SALL4 Is Highly Expressed in Myelodysplastic Syndrome Alongside with NAT10 and P53 (2020) (0)
Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases (2021) (0)
Malignant lymphoma. Advances in diagnosis and treatment. IV. Specific pathological state and etiology. 3. Adult T cell leukemia. (2001) (0)
Core binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis. (2023) (0)
Identification of TIGIT as an HBZ-induced gene by genome-wide analyses: its association with evasion of host defense (2015) (0)
Circadian clock regulates hepatic polyploidy by modulating Mkp1-Erk1/2 signaling pathway (2017) (0)
Title Characterization of simian T-cell leukemia virus type 1 in naturally infected Japanese macaques as a model of HTLV-1 (2019) (0)
Synthesis and Application of Novel Fluorescence-Labeled CXCR4 Antagonists (2008) (0)
Tax-Targeting Dendritic Cell Therapy for ATL: A Phase Ia/Ib Clinical Study (2018) (0)
A case of primary nonleukemic myeloid sarcoma of the spleen, successfully treated by surgery and hematopoietic stem cell transplantation (2021) (0)
[How and why HTLV-1 causes adult T-cell leukemia]. (2021) (0)
[ATL and AIDS]. (2003) (0)
Microarray analysis of WT, HBZ-Tg, IFN-γ KO, and HBZ-Tg/IFN-γ KO mice. (2015) (0)
Virological and imm the pathogenesis of Reviews in (2013) (0)
Establishment of a new cell line (MTT-95) showing basophilic differentiation from the bone marrow of a patient with acute myelogenous leukemia (M7). (1999) (0)
INCREASED MEMORY T-CELLS AND DECREASED NAIVE T-CELLS IN HUMAN T-CELL LEUKEMIA VIRUS INFECTED INDIVIDUALS (1999) (0)
histopathogenesis called Lennert's lymphoma: possible roles of cytokines in An established CD4+ T lymphoma cell line derived from a patient with so- (2011) (0)
533 Extended treatment-free interval with excellent life more than two years after autologous dendritic cell vaccine therapy targeting HTLV-1 Tax for previously treated adult T-cell leukemia/lymphoma: The follow-up kinetics of cytotoxic T lymphocytes and HTLV-1 viral load (2015) (0)
Enhanced antibody-mediated neutralization of HIV-1 variants that are resistant to fusion inhibitors (2016) (0)
adult T cell leukemia Evidence for the interleukin-2 dependent expansion of leukemic cells in (2011) (0)
Discrepant Expression Between mRNA and Protein of HTLV-I Basic Leucine Zipper Factor (HBZ) Makes HTLV-I Infected CD4 Lymphocytes and Adult T Cell Leukemia Cells Less Susceptible to HBZ-Specific Cytotoxic T Lymphocytes (2008) (0)
A-106 Strategy and pathogenesis of human T-cell leukemia virus type 1 (2019) (0)
[Recent advances in molecular pathogenesis of HIV infection]. (2002) (0)
Oncometabolite-Independent Anti-Apoptotic Feature Via Phospholipid Metabolic Adaptation in IDH2 Mutant AML Cells (2022) (0)
Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma. (2023) (0)
Targeting vulnerabilities of adult T-cell leukemia. (2022) (0)
Helicobacter kumamotonensis sp. nov., isolated from human clinical specimens. (2023) (0)
USEFULNESS OF PERCUTANEOUS CATHETER DRAINAGE GUIDED BY ULTRASOUND IN A CASE OF PANCREATIC ABSCESS (1985) (0)
Political Parties in Japan (2010) (0)
Assessing the treatment effect of daratumumab by serial measurements of cardiac biomarkers and imaging parameters in light-chain cardiac amyloidosis. (2022) (0)
[Application of the Tracker Infusion Catheter to hepatic tumors]. (1990) (0)
Expression of the HT462 antigen on fresh leukemic T cells and on cells of HTLV-I infected lines. (1987) (0)
for CD30+ Lymphomas Involving the Skin (2007) (0)
[Programs for continuing medical education: B session; 4. Human T-cell leukemia virus type 1 infection]. (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Masao Matsuoka?

Masao Matsuoka is affiliated with the following schools:

Masao Matsuoka's Academic­Influence.com Rankings

Masao Matsuoka's Degrees

Similar Degrees You Can Earn

Why Is Masao Matsuoka Influential?

Masao Matsuoka's Published Works

Published Works

What Schools Are Affiliated With Masao Matsuoka?

Masao Matsuoka's AcademicInfluence.com Rankings